Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 698

1.

Bone mineral density thresholds for pharmacological intervention to prevent fractures.

Siris ES, Chen YT, Abbott TA, Barrett-Connor E, Miller PD, Wehren LE, Berger ML.

Arch Intern Med. 2004 May 24;164(10):1108-12.

PMID:
15159268
2.

An approach to identifying osteopenic women at increased short-term risk of fracture.

Miller PD, Barlas S, Brenneman SK, Abbott TA, Chen YT, Barrett-Connor E, Siris ES.

Arch Intern Med. 2004 May 24;164(10):1113-20.

PMID:
15159269
3.

Health-economic comparison of three recommended drugs for the treatment of osteoporosis.

Brecht JG, Kruse HP, Möhrke W, Oestreich A, Huppertz E.

Int J Clin Pharmacol Res. 2004;24(1):1-10.

PMID:
15575171
4.

Predictive value of low BMD for 1-year fracture outcomes is similar for postmenopausal women ages 50-64 and 65 and Older: results from the National Osteoporosis Risk Assessment (NORA).

Siris ES, Brenneman SK, Miller PD, Barrett-Connor E, Chen YT, Sherwood LM, Abbott TA.

J Bone Miner Res. 2004 Aug;19(8):1215-20. Epub 2004 May 10.

5.

Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.

Siris ES, Baim S, Nattiv A.

Postgrad Med. 2010 Jan;122(1):82-90. doi: 10.3810/pgm.2010.01.2102. Review.

PMID:
20107292
6.

Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group.

Hochberg MC, Ross PD, Black D, Cummings SR, Genant HK, Nevitt MC, Barrett-Connor E, Musliner T, Thompson D.

Arthritis Rheum. 1999 Jun;42(6):1246-54.

7.

Osteodensitometry in healthy postmenopausal women.

[No authors listed]

Prescrire Int. 2008 Apr;17(94):68-72.

PMID:
18536138
8.

Low bone mineral density and fracture burden in postmenopausal women.

Cranney A, Jamal SA, Tsang JF, Josse RG, Leslie WD.

CMAJ. 2007 Sep 11;177(6):575-80.

9.

A claims database analysis of persistence with alendronate therapy and fracture risk in post-menopausal women with osteoporosis.

Gold DT, Martin BC, Frytak JR, Amonkar MM, Cosman F.

Curr Med Res Opin. 2007 Mar;23(3):585-94.

PMID:
17355739
10.

Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study.

Barrett-Connor E, Wehren LE, Siris ES, Miller P, Chen YT, Abbott TA 3rd, Berger ML, Santora AC, Sherwood LM.

Menopause. 2003 Sep-Oct;10(5):412-9.

PMID:
14501602
11.

Perimenopausal bone density screening--will it help prevent osteoporosis?

Garton MJ, Cooper C, Reid D.

Maturitas. 1997 Jan;26(1):35-43.

PMID:
9032745
12.

[Bisphosphonate treatment prevents hip fractures in 70-79 year old women with osteoporotic vertebral fractures].

Netelenbos JC.

Ned Tijdschr Geneeskd. 2001 Jul 14;145(28):1336-8. Review. Dutch.

PMID:
11484428
13.

Identifying postmenopausal women at high risk of fracture in populations: a comparison of three strategies.

Buist DS, LaCroix AZ, Manfredonia D, Abbott T.

J Am Geriatr Soc. 2002 Jun;50(6):1031-8.

PMID:
12110062
14.

Osteoporosis prevalence and levels of treatment in primary care: the Australian BoneCare Study.

Eisman J, Clapham S, Kehoe L; Australian BoneCare Study.

J Bone Miner Res. 2004 Dec;19(12):1969-75. Epub 2004 Sep 13.

15.
16.

Prevalence of risk factors for referring post-menopausal women for bone densitometry. The INSTANT study.

Roux C, Fardellone P, Lespessailles E, Cotté FE, Mercier F, Gaudin AF.

Joint Bone Spine. 2008 Dec;75(6):702-7. doi: 10.1016/j.jbspin.2007.12.007. Epub 2008 Jul 9.

PMID:
18617431
17.

Prediction of fracture risk in postmenopausal white women with peripheral bone densitometry: evidence from the National Osteoporosis Risk Assessment.

Miller PD, Siris ES, Barrett-Connor E, Faulkner KG, Wehren LE, Abbott TA, Chen YT, Berger ML, Santora AC, Sherwood LM.

J Bone Miner Res. 2002 Dec;17(12):2222-30.

18.

Pharmacologic prevention of osteoporotic fractures.

Zizic TM.

Am Fam Physician. 2004 Oct 1;70(7):1293-300. Review.

19.

[Guidelines for drug therapy of postmenopausal osteoporosis].

Dimai HP, Pietschmann P, Resch H, Leb G, Klaushofer K.

Wien Med Wochenschr. 2002;152(23-24):596-612. Review. German.

PMID:
12530170
20.

Hot flushes, bone mineral density, and fractures in older postmenopausal women.

Huang A, Grady D, Blackwell T, Bauer D.

Obstet Gynecol. 2007 Apr;109(4):841-7.

PMID:
17400844

Supplemental Content

Support Center